Palantir · U.S. · Wired · Wired
The Single English County Saying No to Palantir
Compiled by KHAO Editorial — aggregated from 1 source. See llms.txt for citation guidance.
◌ Single Source
The UK government has six months to decide whether to terminate a deal worth more than $400 million between the country’s National Health Service and American software company Palantir.
Key facts
- The UK government has six months to decide whether to terminate a deal worth more than $400 million between the country’s National Health Service and American software company Palantir
- In 2023, the UK commissioned Palantir to develop a “ federated data platform ” (FDP) that could ingest and organize the tangle of health data produced across the country
- [Even] a technically strong platform will struggle to realize value if clinicians, data controllers, patients or the public do not trust it,” Matt Hennessey, chief data and analytics officer at NHS
- That claim—disputed by Palantir and other FDP advocates—has fed into a national debate over whether the government should seize an opportunity next February to terminate the NHS contract early
Summary
In 2023, the UK commissioned Palantir to develop a “ federated data platform ” (FDP) that could ingest and organize the tangle of health data produced across the country. But lately, as Palantir technology is deployed in theatres of war and the US administration’s immigration crackdown, its deal with the NHS has become a flashpoint in the UK, drawing protests, petitions, parliamentary inquiries, and a reported rebellion among NHS workers. The health care board for one part of England, Greater Manchester, has repeatedly declined to adopt Palantir’s FDP, choosing to stick with a home-spun platform developed over the best part of a decade.